SUMMARY
We assessed cell subsets and expression of a set of genes related to the T-cell populations in peripheral blood mononuclear cells to elucidate whether immune status of stable hand transplant recipients (HTx) differs from stable kidney transplant recipients (KTx). The study was conducted on five HTx 4.8 AE 1.7 years after transplantation and 30 stable KTx 7.9 AE 2.4 years after transplantation as well as 18 healthy volunteers. The research involved PBMC gene expression analysis of CD4, CD8, CTLA4, GZMB, FOXP3, IL10, IL4, ILR2A, NOTCH, PDCD1, PRF1, TGF-B, and TNF-A genes on a custom-designed low-density array (TaqMan) as well as flow cytometry assessment of lymphocyte subpopulations. HTx presented significantly increased expression of immunomodulatory genes (TNF, IL10, GITR, and PDCD1) compared to KTx and controls. HTx revealed a proinflammatory molecular pattern with higher expression of NOTCH and CD8 compared to KTx and controls. KTx showed a reduced level of regulatory T cells compared to controls and HTx. Both HTx and KTx presented an increased number of CD8 + and CD8 + CD28 À T cells compared to controls. Stable hand transplant recipients exhibit persistent immune activation with rejection-related gene expression pattern counterbalanced by secondary induction of regulatory mechanisms.
Introduction
The long-term outcome of transplantation depends not only on the surgical skills of the transplant surgeon but also on subsequent adaptive immune responses to the grafted tissues. Interaction of donor major histocompatibility complex with recipients T lymphocytes initiates T-cell activation and the subsequent antigraft response. The effector stage of rejection is characterized by upregulation of cell surface receptors, cytokines, adhesion molecules, and apoptosis-related markers. In spite of immunosuppressive therapy, the rate of reversible acute rejection is almost 100% in vascularized composite allotransplantation (VCA) and together with chronic rejection may lead to allograft loss [1, 2] .
Induction of donor-specific tolerance is a main goal in transplantation. Hand transplantation is not a lifesaving or life-extending procedure, so the biological risk of long-lasting immunosuppression is widely discussed. Operational tolerance may free transplant recipients from side effects of immunosuppressive therapy, as well as improving long-term results by cessation of acute and chronic rejection. Many studies have been performed to assess the possibility of inducing tolerance in hand transplant recipients so far [3, 4] .
Naturally occurring regulatory T cells (Tregs) have been recognized as a T-cell subset with immunomodulatory properties. They play an important role in immune regulation after organ transplantation, and they have been proven to prevent allograft rejection.
Long-term stimulation with alloantigens after transplantation leads to conversion of potential effector cells into Tregs with graft-protective properties. The hallmark of regulatory activity of Tregs is the expression of FOXP3 transcription factor but also increased expression of some other genes, which are upregulated in the presence of donor-specific tolerance [5, 6] .
It is an open question whether immune activationand regulation-related patterns differentiate stable VCA recipients from stable solid organ transplants and whether lessons from solid organ transplantation may be directly applied to VCA.
The goal of the study was to describe the immune status of stable hand transplant recipients (HTx) in relation to stable kidney recipients (KTx) and healthy volunteers. The gene expression and lymphocyte subpopulations were analyzed in the search for hallmarks of hand transplant acceptance.
Materials
The study was approved by the Bioethical Committee of Wroclaw Medical University and performed in accordance with the World Medical Association Declaration of Helsinki, and the participants provided fully informed consent.
The study was conducted on five hand transplant recipients (HTx; four males, one female, aged 40 AE 11 years at the time of examination), transplanted between 2006 and 2010 in the Subdepartment of Replantation of Limbs, St. Hedwig District Hospital, in Trzebnica. The study group included recipients who were transplanted at the level of the distal forearm (two recipients), the wrist, the upper arm, and bilateral HTx (wrist). All the recipients presented negative T-and Bcell cross-matches before transplantation. HLA mismatches were 5, 5, 3, 5, and 4, respectively. All of the recipients experienced at least one skin rejection episode, treated with corticosteroids and topical tacrolimus [7] . None of the recipients revealed histological signs of skin rejection at the time of evaluation (control biopsies showed Banff grade 0) or 12 months before and after examination. None of the HTx recipients showed presence of DSA (donor-specific antibodies) before and at the moment of examination as we previously described [8] .The initial immunosuppressive therapy consisted in all cases of basiliximab, corticosteroids, tacrolimus, and mycophenolate mofetil. The blood samples were collected 4.8 AE 1.7 years after HTx. The immunosuppression at the time of examination is presented in Table 1 .
The results were compared to data for 30 stable kidney transplant recipients (KTx) transplanted in the Department of Vascular, General and Transplantation Surgery and followed up in the Department of Nephrology and Transplantation Medicine, Wroclaw Medical University. The samples were chosen from our biobank with best possible match to HTx group (according to clinical and transplant features). They were 21 males and nine females, with the mean age of 37 years, at the time of transplantation. None of the recipients revealed clinical signs of kidney rejection at the time of evaluation. The kidney allograft function was preserved, with the mean serum creatinine concentration 1.25 AE 0.15 mg/dl at the moment of examination. No infection, PTLD/lymphoma/tumor, and rejection were present in the preceding 12 months prior to the study. The blood samples were collected from 4 to 12 years (7.9 AE 2.4) after KTx.
The study also included 18 healthy volunteers (10 males, eight females; age 46 AE 13 years). The clinical parameters of examined HTx patients and KTx group are described in Table 2 .
Methods

Gene expression
Gene expression studies were performed on PBMC isolated from heparinized blood using density gradient centrifugation on Histopaque-1077 (Sigma-Aldrich, Poznan, Poland). RNA was purified from samples of 2 9 10 6 PBMC with the RNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol including genomic DNA removal with RNase-free DNase (Qiagen, Hilden, Germany). The samples were reversely transcribed with the HighCapacity cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, CA, USA). 10 ll of final reaction volume in 100 ll of TaqMan PCR Master Mix was applied to each channel of custom-designed low-density array (TaqMan) and analyzed on a TaqMan 7900HT instrument.
The research involved triplicate analysis of
TNF-A (Hs00174128_m1), andGITR (Hs00188346_m1) with two candidate reference sequences: 18S rRNA (Hs99999901_s1) and GAPDH (Hs99999905_m1).
The relative expression data were calculated using 18S rRNA as a reference gene and the healthy volunteer group as a reference group. The expression data were averaged from triple measurement points and are presented as DDCt = mean ΔCt ref À ΔCt sample , where ΔCt = Ct 18S À Ct gene , Ct is the cycle threshold value and defines the calculated cycle number, in which the fluorescence measured during PCR reaction increases over the preset threshold value. The relative expression level can be further calculated as 2
DDCt .
Cell phenotypes
Antibodies
The following mouse anti-human antibodies (Becton Dickinson, Warsaw, Poland) were used for cell phenotyping: anti-CD3-APC (clone UCHT1), anti-CD4-PerCP (clone SK3), anti-CD25-FITC (clone M-A251), anti- Table 2 . Clinical parameters of examined groups. 
CD28-PE (clone CD28.2), anti-CD8-FITC (RPA-T8), and anti-CD127-PE (clone hIL-7R-M21).
Whole-blood staining
The samples of whole blood were stained with anti-CD3-APC, anti-CD4-PerCP, anti-CD25-FITC, and anti-CD127-PE for CD3 + CD4 + CD25 + CD127 low phenotyping and with anti-CD3-APC, anti-CD8-FITC, and anti-CD28-PE for CD3 + CD8 + CD28
À . After incubation, the samples were lysed with BD FACS Lysing Solution, washed with PBS, and subjected to analysis on a FACSCalibur flow cytometer (Becton Dickinson, Warsaw, Poland). The subpopulations were counted in relation to total lymphocytes.
Flow cytometry gating strategy
In case of T, B, and NK, the gating strategy followed the manufacturer protocol for cell counting in the Trucount tubes. To enumerate the T-cell subpopulations, lymphocytes were gated based on forward and side scatter. CD3 + CD4 + cells were selected on CD4 versus CD3 plot. The CD3 + CD4 + cells were further displayed on CD25 versus CD127 plot and CD25 + CD127 low gate described Tregs. CD8 CD28 neg cells were calculated from CD8 versus CD28 plot of the CD3 + lymphocyte gate. The absolute counts were obtained using T/ll from Multitest assay and the subpopulation ratios.
Statistical analysis
Cell populations and gene expression data are presented as mean AE SD for HTx, KTx, and control groups. The HTx group results are also presented in a case-related manner. Gene expression data were statistically analyzed as DDCt that showed normal distribution. The comparisons between the study groups were performed with t-test. The significance level of a = 0.05, and the Bonferroni-Holm correction for multiple testing was included for cell populations and expression data families [9] . Throughout the text, the adjusted P-values are shown. Statistical analysis was performed using the STATIS-TICA v.10 statistical package (StatSoft, Cracow, Poland).
Results
The detailed cell phenotypes for the hand transplant recipients are presented in Table 3 , and the statistical data for study groups are summarized in Table 4 .
Standard lymphocyte phenotyping revealed that total T-and NK-cell counts (numbers of cells per microliter) did not differ significantly between studied groups (Table 4) . However, in case of both transplant groups, there was a shift to increased number of CD8 + (KTx P = 0.005 and HTx P = 0.035). HTx presented level of B cells similar to controls, while in case of KTx, the fourfold depletion of B cells was observed (P < 0.001).
In the case of hand transplant recipients, the Treg population size (CD4 + CD25 + CD127 low absolute count) was similar to the healthy control group. The analysis of kidney transplant recipient group showed reduced size of Treg population compared to controls (P < 0.001).
Together with the increased CD8 + population of T lymphocytes, a strong CD28 negativity was observed in HTx with eightfold increase in absolute cell counts compared to controls (P = 0.003). Similar phenomenon was observed in KTx with 10-fold increase in absolute cell counts compared to controls (P < 0.001).
The gene expression data were obtained for all measurement points except for few IL4 assays. The descriptive statistics of expression data are shown in Table 5 . The hand transplant recipients presented significantly higher DDCT values of most examined genes, both regulatory and activatory compared to the KTx and control groups (Fig. 1) .
In the HTx group, several genes were upregulated compared to the control group: CD8 (7.7-fold, P = 0.003), IL10 (8.3-fold, P = 0.015), NOTCH1 (19-fold, P < 0.001), PDCD1 (2.9-fold, P = 0.038), TNF (5.2-fold, P = 0.006), and GITR (fivefold, P = 0.002).
In the KTx group, no gene expression differed from the control group.
The expression levels also differentiated HTx from KTx group. From the regulatory genes, only GITR was significantly upregulated in the HTx group (fivefold, P < 0.001).
Also, the rejection-related genes such as CD8, NOTCH, and TNF were expressed at a higher level in the HTx group (3.8-fold, P = 0.011; 16.3-fold, P < 0.001; 3.7-fold, P = 0.002).
Discussion
In our study, we demonstrated for the first time that stable hand transplant recipients (HTx) differ from stable kidney transplant recipients (KTx) in relation to gene expression and T-cell subsets. Rejection-related molecular pattern (expression of TNF, NOTCH, and CD8) was increased in HTx compared to KTx and healthy controls. Moreover, an immunomodulatory molecular pattern with upregulation of IL10, GITR, and PDCD1 was noted in HTx when compared to KTx or controls. Vascularized composite allotransplantation contains skin, which is one of the most immunogenic tissue types, with more T effector cells than in blood [10, 11] . On the other hand, VCA, unlike solid allografts, may be regarded as a vascularized bone marrow transplant with donor hematopoietic stem cells engrafting in the recipient bone marrow and thus promoting tolerance to donor-specific tissues [12-15]. However, the spontaneous development of mixed chimerism in VCA recipients is not frequent [16] , and donor-specific hyporesponsiveness did not develop clinically in VCA [12, 17] .
Recipients of VCA are treated with immunosuppression reflecting that used in organ transplantation; however, it proves ineffective in preventing early rejection episodes in 100% of hand transplant recipients [18, 19] . Because of high rate of rejection episodes, the total immunosuppression burden in VCA is generally high so it may be expected that the state of partial immune quiescence could develop in stable VCA recipients.
Despite the possibility of HTx recipients becoming quiescent, we observed that the following potent markers of the immune activation [20] [21] [22] Although in the first part of our research, we demonstrated increased proinflammatory, rejection-related status of the stable hand transplant recipients at the cellular level, we also noted that it is counterbalanced by the cell populations and expression of genes related to T regulatory cells phenotype. To show functional immunomodulatory path of immune response, we also examined phenotypic gene markers of Tregs: FOXP3, CTLA4, and GITR with genes coding mediators of Treg functions: TGFB, IL10, and PDCD1. In our study, despite high immunosuppression load, HTx present the same Treg level as healthy controls, which is not the case in KTx that presented lower Treg cell counts. Hand transplant recipients did not differ according to FOXP3 expression levels from stable kidney transplant recipients or healthy controls; however, other functional markers of Tregs (IL10, GITR, and PDCD1) were upregulated in HTx compared to KTx or controls. GITR, highly expressed on Tregs, serves as a counterbalance to CTLA-4 engagement [46] with high expression levels in operationally tolerant kidney transplant recipients [6] . Inhibition of the CTLA-4 pathway was demonstrated to be effective in achieving immunosuppression in composite tissue transplants [47] . Together with PDCD1 and CTLA-4, IL-10 belongs to functional markers of Tregs and inhibits T-cell responses [32, 48] .
According to our knowledge, this is the first published report concerning increased expression of IL10, GITR, and PDCD1 expression in stable HTx, suggesting robust immunoregulatory potential.
In summary, we have demonstrated for the first time that stable hand transplant recipients with no signs of rejection do not present "immune quiescence." As an effect of persistent immune activation, an immunomodulation-associated molecular pattern is observed probably as a safety mechanism to prevent uncontrolled overactivation of the immune response. Moreover, the mechanisms are not silenced by a high immunosuppression load in hand transplant recipients and are enhanced during repeated rejection episodes. The hypothesis is supported by growing data on chronic rejection cases among composite tissue allograft recipients [2] .
The limitation of our study includes the small number of HTx that reflects the worldwide scarcity of VCA procedures. There was no possibility to match the HTx and KTx according to total immunosuppression load. Many skin rejection episodes resulted in multiple increases in steroid dosage, whereas repeating episodes of kidney rejection usually lead to allograft loss not to long-term stable graft function.
Conclusion
Despite the small size of the study group, we have shown that stable hand transplant recipients exhibit persistent immune activation with rejection-related gene expression pattern counterbalanced by secondary induction of immunomodulatory mechanisms. 
